Crystalline Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Crystalline Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-37,177	Closed	-$689K	–	130
2023 Q3	$689K	Buy	+37,177	New	+$421K	0.49%	53

Crystalline Management's ICPT Position: Q4 2023 in Review

Crystalline Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 37,177 shares — an estimated $689K sold.

Crystalline Management first reported a position in ICPT in Q3 2023 and held it in 1 quarter. The position peaked at $689K in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

Crystalline Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
Crystalline Management sold 37,177 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $689K.
Crystalline Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2023 and held it in 1 quarter.
Crystalline Management's Intercept Pharmaceuticals, Inc. position peaked at $689K in Q3 2023.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Crystalline Management's 13F filing for Q4 2023, filed 12 Feb 2024.